Fischer, Lilith and Paschke, Bjarne and Gareis, Franziska and Schumacher, Michael and Liere, Philippe and Hiergeist, Andreas and Gessner, Andre and Rupprecht, Rainer and Neumann, Inga D. and Bosch, Oliver J. (2025) The translocator protein 18 kDa (TSPO) ligand etifoxine in an animal model of anxiety: Line- and sex-dependent effects on emotionality, stress reactivity, spine density, oxytocin receptors, steroids, and microbiome composition. NEUROPHARMACOLOGY, 266: 110282. ISSN 0028-3908, 1873-7064
Full text not available from this repository. (Request a copy)Abstract
The treatment of stress-related disorders such as anxiety and depression is still challenging. One potential therapeutical option are neurosteroids. Their synthesis is promoted by ligands of the mitochondrial translocator protein 18 kDa (TSPO). We tested the TSPO ligand etifoxine (ETX) in a rat model of hyper-anxiety and depression-like behavior, i.e., in female and male HAB (high anxiety-related behavior) rats, as well as in respective low anxiety (LAB) and non-selected control (NAB) rats for behavioral, molecular, cellular, and physiological parameters. Daily acute i.p. treatment with ETX or vehicle over 5 or 9 days revealed that ETX was most effective in female HAB rats; it reduced anxiety levels (5 days) and OXT-R binding brain site-specifically (5 and 9 days), and increased spine density (5 days). The behavioral ETX effect exclusively found in female HABs was accompanied by increased 3 beta 5 alpha-THDOC levels, without any effect in female LABs and NABs and on other neurosteroids. In males of all breeding lines, ETX changed a total of 10 out of 23 brain steroids. Passive stresscoping during 10-min forced swimming was not affected by 9-day treatment with ETX, the resulting stressinduced plasma corticosterone levels were higher in ETX-treated NAB rats of both sexes compared with their VEH-treated groups. The fecal bacterial composition was similar but beta diversity differed between HABs and LABs and from NABs independent of sex; ETX treatment had no effect. Therefore, we propose considering the aspect of sex in treatment strategies for anxiety disorders. This is particularly important to establish better treatment regimens for women.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | NEUROACTIVE STEROIDS; BENZODIAZEPINE-RECEPTOR; PLASMA-CONCENTRATIONS; THERAPEUTIC TARGET; MAJOR DEPRESSION; BRAIN; BEHAVIOR; ALLOPREGNANOLONE; VASOPRESSIN; DISORDERS; Anxiety-related behavior; Corticosterone; Etifoxine; Passive stress-coping; Spine density; TSPO |
| Subjects: | 500 Science > 590 Zoological sciences 600 Technology > 610 Medical sciences Medicine |
| Divisions: | Medicine > Lehrstuhl für Medizinische Mikrobiologie und Hygiene Medicine > Lehrstuhl für Psychiatrie und Psychotherapie Biology, Preclinical Medicine > Institut für Zoologie > Tierphysiologie/Neurobiologie (Prof. Dr. Inga Neumann) |
| Depositing User: | Dr. Gernot Deinzer |
| Date Deposited: | 19 Oct 2026 09:58 |
| Last Modified: | 19 Oct 2026 09:58 |
| URI: | https://pred.uni-regensburg.de/id/eprint/66228 |
Actions (login required)
![]() |
View Item |

